Perspectives From Our Scientists

The new gold standard for C. difficile Infection is now the murine model which TransPharm Preclinical Solutions developed in 2012.

Custom Infection Model Development is an important tool used for Infectious Disease research. Numerous pathogens can be used in our models.

TransPharm Preclinical Solutions' Infection Models Reduce Study Risk using a barrage of internal quality controls.

Translating In Vitro Results into In Vivo Success can be tricky, but also a very useful and economical way to find activity of your test material.

The Osteomyelitis Rat Model has shown to be extremely consistent and useful in testing new Antibacterial compounds.

Infectious Disease in vivo models are unique in that you have numerous options when it comes to endpoints, including bacterial burden or mortality.

Often times, the standard animal models simply don't provide all the answers you need. Model validation is paramount to customize these models.

Being the best CRO may mean different things to different people.  For TransPharm , our first task is to find out what is most important to you.

Rodent Models are used when developing new Anti-infectives due to ease of use, cost and minimal requirements for available material.